Bristol-Myers Squibb’s ZymoGenetics R&D facility earns LEED Silver Certification
Bristol-Myers Squibb announced that it's ZymoGenetics R&D Facility in Seattle earned a LEED Silver Certification from U.S. Green Building Council. LEED certification is recognized worldwide as the premier mark of achievement in green building. October 31, 2014